Hui Kang
- Pharmacology top 10%
-
- Advanced biosensing and bioanalysis techniques 2
- Glycosylation and Glycoproteins Research 1
- Cell death mechanisms and regulation 1
- Pluripotent Stem Cells Research 1
-
- Acute Myeloid Leukemia Research 1
-
- Cancer Cells and Metastasis 4
-
- Microfluidic and Bio-sensing Technologies 2
- 3D Printing in Biomedical Research 2
- Co-authors
- Li GaoGuang‐Biao ZhouFengxiang ZhangXiangqin WengMing YanZhixiang ShenZhenyi WangChen Zhu
- Journals
- Analytical Chemistry (2 papers)Blood (1 paper)ACS Biomaterials Science & Engineering (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hui Kang
9 papers receiving 360 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 47
- Molecular Biology 301
- Hematology 36
- Cancer Research 46
- Genetics 32
Countries citing papers authored by Hui Kang
This map shows the geographic impact of Hui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Kang more than expected).
Fields of papers citing papers by Hui Kang
This network shows the impact of papers produced by Hui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Kang. The network helps show where Hui Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 97 | |
| 9 | 2021 | 5 | |
| 10 | A bispecific aptamer targeting both VEGF and Angiopoietin-2 for treating retinal diseases | 2019 | 1 |
| 11 | 2019 | 61 | |
| 12 | 2006 | 183 |
About Hui Kang
Hui Kang is a scholar working on Genetics, Oncology and Cancer Research, having authored 12 papers that have together received 363 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Microfluidic and Bio-sensing Technologies (2 papers), 3D Printing in Biomedical Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Glycosylation and Glycoproteins Research (1 paper), Acute Myeloid Leukemia Research (1 paper), Cell death mechanisms and regulation (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Pharmacology (47 citations), Molecular Biology (301 citations) and Hematology (36 citations). Hui Kang has collaborated with scholars based in China and United States. Frequent co-authors include Li Gao, Guang‐Biao Zhou, Fengxiang Zhang, Xiangqin Weng, Ming Yan, Zhixiang Shen, Zhenyi Wang, Chen Zhu, Ping Liu and Sai‐Juan Chen. Their work appears in journals such as Analytical Chemistry, Blood, ACS Biomaterials Science & Engineering, Nature Communications and Journal of Materials Science Materials in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.